RE: Happy Avacta New Year27 Dec 2023 13:35
Oh dear oh dear, Eggy I thought we had cleared this up for you when you first tried peddling this erroneous argument. To quote your recent (I assume attempted implied slur):
(Thanks by the way for Ophidian's cut and paste trip down memory lane RE pharmacodynamics and compartments/distribution models etc although I must confess I'm not sure what, if anything, it has to do with the AUC stats.)
The fact that you are "not sure what it has to do with the AUC" is exactly why you parade you ignorance. Try even thinking about what the units for the AUC are (let me help ---> h.ng/ml or maybe h.mg/L - both may typically be used - it is a measure of the amount of drug per unit volume of blood per hour)
It is all about clearance - as I tried to explain in the piece I shared that you seek to malign, the criticality is around not exceeding the levels that the body can adequately deal with clearing. Hence as multiple people have tried to point out to you the SIGNIFICANT difference in Cmax is what is most illuminating and pertinent here. It would not be reasonable to expect a very very low doxorubicin plasma concentration and still expect to be seeing clear and obvious efficacy in some patients. The 40-80% reduction in doxorubicin plasma concentration compared to standard dosed doxorubicin compared to AVA6000 dosed doxorubicin (at a substantially higher relative concentration too btw, is remarkable).
I know he's gong to continue to blather on and try and argue black is white - I won't be drawn in to another exchange - but I would urge everyone to simply look at the available explanations and just simply ignore the total nonsense this guy tries to peddle.